METHODS FOR KILLING PSMA-EXPRESSING, TAXANE-RESISTANT CANCER CELLS

摘要

Methods of killing prostate-specific membrane antigen (PSMA)-expressing, taxane- resistant cancer cells are provided. In particular, PSMA-expressing, taxane-resistant cancer cells are contacted with an antibody-drug conjugate (ADC) that comprises an antibody or antigen-binding fragment thereof that specifically binds to PSMA conjugated to monomethylauristatin norephedrine or monomethylauristatin phenylalanine.